Endogenous DOPA inhibits melanoma through suppression of CHRM1 signalingMiriam Doepner, Todd W. Ridky|Science Advances|2022Cited by 24
CHRM1 is a Druggable Melanoma Target Whose Endogenous Activity is Determined by Inherited Genetic Variation in DOPA ProductionMiriam Doepner|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0